Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-05 1:23 pm Purchase | 2024-12-31 | 13G | Relay Therapeutics, Inc. RLAY | BlackRock Inc. BLK | 14,674,262 8.800% | 5,100,839 (+53.28%) | Filing History |
| 2024-11-14 1:22 pm Sale | 2024-09-30 | 13G | Relay Therapeutics, Inc. RLAY | PRICE T ROWE ASSOCIATES INC | 5,280,291 3.300% | -3,309,134 (-38.53%) | Filing History |
| 2024-02-14 4:20 pm Purchase | 2023-12-31 | 13G | Relay Therapeutics, Inc. RLAY | Casdin Capital, LLC | 7,387,943 5.990% | 1,089,369 (+17.30%) | Filing History |
| 2024-02-14 10:03 am Purchase | 2023-12-31 | 13G | Relay Therapeutics, Inc. RLAY | PRICE T ROWE ASSOCIATES INC | 8,589,425 7.000% | 8,589,425 (New Position) | Filing History |
| 2024-02-13 5:13 pm Purchase | 2023-12-29 | 13G | Relay Therapeutics, Inc. RLAY | VANGUARD GROUP INC | 10,650,387 8.640% | 266,169 (+2.56%) | Filing History |
| 2024-01-26 11:49 am Purchase | 2023-12-31 | 13G | Relay Therapeutics, Inc. RLAY | BlackRock Inc. BLK | 9,573,423 7.800% | 1,575,438 (+19.70%) | Filing History |
| 2024-01-23 09:35 am Sale | 2023-12-31 | 13G | Relay Therapeutics, Inc. RLAY | STATE STREET CORP STT | 4,903,578 3.980% | -1,360,919 (-21.72%) | Filing History |
| 2023-10-02 4:14 pm Purchase | 2023-09-21 | 13G | Relay Therapeutics, Inc. RLAY | Casdin Capital, LLC | 6,298,574 5.160% | 6,298,574 (New Position) | Filing History |
| 2023-07-10 10:20 am Sale | 2023-07-07 | 13G | Relay Therapeutics, Inc. RLAY | FMR LLC | 2,956,221 2.430% | -6,777,627 (-69.63%) | Filing History |
| 2023-02-09 12:31 pm Sale | 2023-02-09 | 13G | Relay Therapeutics, Inc. RLAY | FMR LLC | 9,733,848 8.051% | -2,224,364 (-18.60%) | Filing History |
| 2023-02-09 11:30 am Purchase | 2022-12-30 | 13G | Relay Therapeutics, Inc. RLAY | VANGUARD GROUP INC | 10,384,218 8.590% | 4,185,776 (+67.53%) | Filing History |
| 2023-02-03 3:11 pm Purchase | 2022-12-31 | 13G | Relay Therapeutics, Inc. RLAY | STATE STREET CORP STT | 6,264,497 5.180% | 6,264,497 (New Position) | Filing History |
| 2023-01-31 5:52 pm Purchase | 2022-12-31 | 13G | Relay Therapeutics, Inc. RLAY | BlackRock Inc. BLK | 7,997,985 6.600% | 2,004,372 (+33.44%) | Filing History |
| 2022-10-11 09:03 am Sale | 2022-10-07 | 13G | Relay Therapeutics, Inc. RLAY | FMR LLC | 11,958,212 9.947% | -4,248,389 (-26.21%) | Filing History |
| 2022-02-14 4:52 pm Sale | 2021-12-31 | 13G | Relay Therapeutics, Inc. RLAY | Third Rock Ventures III L.P. | 362,619 0.300% | -10,188,496 (-96.56%) | Filing History |
| 2022-02-10 08:32 am Purchase | 2021-12-31 | 13G | Relay Therapeutics, Inc. RLAY | VANGUARD GROUP INC | 6,198,442 5.740% | 6,198,442 (New Position) | Filing History |
| 2022-02-09 10:24 am Purchase | 2022-02-08 | 13G | Relay Therapeutics, Inc. RLAY | FMR LLC | 16,206,601 14.999% | 5,844,601 (+56.40%) | Filing History |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | Relay Therapeutics, Inc. RLAY | BlackRock Inc. BLK | 5,993,613 5.500% | 5,993,613 (New Position) | Filing History |
| 2021-07-12 12:07 pm Purchase | 2021-07-09 | 13G | Relay Therapeutics, Inc. RLAY | FMR LLC | 10,362,000 11.216% | 5,599,762 (+117.59%) | Filing History |
| 2021-02-16 4:12 pm Purchase | 2020-12-31 | 13G | Relay Therapeutics, Inc. RLAY | Third Rock Ventures III L.P. | 10,551,115 11.700% | 10,551,115 (New Position) | Filing History |